We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Carotid Stenting in Patients With High Risk Carotid Stenosis ("Soft Plaque") (MOMA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01274676
First Posted: January 11, 2011
Last Update Posted: January 11, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Centro Cardiologico Monzino
  Purpose
Stenting is an alternative to traditional surgery in the treatment of carotid stenosis.The intra and/or postprocedural cerebral embolization remains the most frequent complication. Thanks to the systematic use of cerebral protection systems, these complications have reduced.A debate concerning which cerebral protective device should be more effective is still ongoing.

Condition Intervention
Carotid Stenosis Device: carotid stenting with MOMA Device: Carotid stenting with filter wire EZ

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Randomized Trial of Proximal-versus Distal Cerebral Protection on Micro Embolization During Carotid Artery Stenting in Patients With High Risk Lipid Palque

Further study details as provided by Centro Cardiologico Monzino:

Primary Outcome Measures:
  • number of Microembolization signals (MES) detected with transcranal doppler [ Time Frame: 6 different phases of carotid stenting (lesion wiring; predilation; stent crossing of the lesion; stent deployment; stent post dilation; device tetruieval/deflation ]

Secondary Outcome Measures:
  • Clinical success [ Time Frame: In hospital and 30 days ]
    Assesment of any clinical and neurological complication (death, any stroke, TIA; myocardial infarction).


Enrollment: 53
Study Start Date: February 2009
Study Completion Date: February 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: carotid stenting with MOMA Device: carotid stenting with MOMA
The MOMA system is an endovascular catheter for proximal protection during carotid stenting. The system allows a concomitant balloon occlusion of both external and common carotid arteries leading to blood flow reversal within the internal carotid artery.
Other Name: MOMA device (INVATEC RONCADELLE, BRESCIA - ITALY)
Active Comparator: Carotid stenting with filter wire EZ Device: Carotid stenting with filter wire EZ
The filter wire EZ a distal protection system that is placed in he distal internal carotid artery before carotid stenting. The filter should entrap almost all the debries that are generated during endovascular procedure. At the end of the procedure the filter is retrieved throught a dedicated retrieval catheter.
Other Name: Filterwire EZ - Boston Scientific

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

-patients with monolateral, significant, soft carotid stenosis

Exclusion Criteria:

  • patients with controlateral carotid occlusion
  • patients with critic stenosis of the external carotid
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01274676


Locations
Italy
Centro Cardiologico Monzino, IRCCS
Milan, Italy, 20138
Sponsors and Collaborators
Centro Cardiologico Monzino
Investigators
Principal Investigator: Piero Montorsi, MD Centro Cardiologico Monzino, IRCCS
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Piero Montorsi, MD, Centro Cardiologico Monzino, IRCCS
ClinicalTrials.gov Identifier: NCT01274676     History of Changes
Other Study ID Numbers: S111/508
First Submitted: January 10, 2011
First Posted: January 11, 2011
Last Update Posted: January 11, 2011
Last Verified: September 2009

Keywords provided by Centro Cardiologico Monzino:
stenting
carotid plaque
stenosis
angioplasty

Additional relevant MeSH terms:
Constriction, Pathologic
Carotid Stenosis
Pathological Conditions, Anatomical
Carotid Artery Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases